Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02540122 · ClinicalTrials.gov registry record · Phase 1
Pilot Clinical Evaluation of Approved Contact Lenses
A Phase 1 study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT02540122 is a Phase 1 study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 30 participants.
The verdict
NCT02540122, a Phase 1 study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a pilot evaluation to assess the feasibility of using novel imaging process to characterize lens edge and limbal epithelial thickness profile; lens movement with gaze and blink; and conjunctival microvasculature including fractal analysis of microvascular perfusion maps and blood flow velocity.
Interventions
- DEVICE Marketed Contact Lens 1
- DEVICE Marketed Contact Lens 2
- DEVICE Marketed Contact Lens 3
- DEVICE Marketed Contact Lens 4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02540122
The ClinicalTrials.gov registry entry for NCT02540122 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Marketed Contact Lens 1 is the first listed.
NCT02540122 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02540122 about?
NCT02540122 is a clinical study titled "Pilot Clinical Evaluation of Approved Contact Lenses". This is a pilot evaluation to assess the feasibility of using novel imaging process to characterize lens edge and limbal epithelial thickness profile; lens movement with gaze and blink; and conjunctival microvasculature including fractal analysis of microvascular perfusion maps and blood flow veloci...
What is the current status of trial NCT02540122?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2015-08. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02540122?
The interventions under investigation include: Marketed Contact Lens 1 (DEVICE), Marketed Contact Lens 2 (DEVICE), Marketed Contact Lens 3 (DEVICE), Marketed Contact Lens 4 (DEVICE).
Who is sponsoring clinical trial NCT02540122?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.